| International business 3 year | Presentations submission timeliness, slide quality, oratorical art, audience involvement in the company analysis 0-3 | Size and uniqueness of the analyzed company 0-3 | The width of the analysis performed, i.e. whether enough work has been done 0-4 | Depth of the case analysis, i.e. use sophisticated analytical techniques 0-4 | It was collected an additional, interesting and valuable material on the Internet 0-2 | Summary, conclusions, what gave the analysis 0-2 | Working as opponent of the peer presentations or active participation in the cases analysis 0-1. | ||||||
| # | Company name | Participants / Opponents | Date of presentation | Presentations queue | Assessment | ||||||||
| 1 | FedEx | Anhelina Valkavets | 2022-12-08 | 1 | 0 | ||||||||
| FedEx | Hanna Beraziuk | 2022-12-08 | 1 | 0 | |||||||||
| 2 | Pfizer, Inc | Yuliya Mironava | 2022-11-24 | 1 | 10 | 3 | 2 | 2 | 1 | 1 | 1 | ||
| 3 | LUFTHANSA | Jules JACQUEMIN | 2022-11-24 | 2 | 10 | 3 | 2 | 2 | 1 | 1 | 1 | ||
| 4 | LUFTHANSA | Alexandre PIOT | 2022-11-24 | 2 | 9 | 3 | 2 | 2 | 1 | 1 | |||
| 5 | LUFTHANSA | Louise BERTHAUD-FOUACHE | 2022-11-24 | 2 | 9 | 3 | 2 | 2 | 1 | 1 | |||
| 6 | Amazon | Michaela Kleynhans | 2022-11-24 | 3 | 9 | 3 | 2 | 2 | 1 | 1 | |||
| 7 | Amazon | Agnė Mažeikaite | 2022-11-24 | 3 | 10 | 3 | 2 | 2 | 1 | 1 | 1 | ||
| 8 | Amazon | Karolina Visockyte | 2022-11-24 | 3 | 9 | 3 | 2 | 2 | 1 | 1 | |||
| 9 | BioNTech | Thibault Schlez | 2022-11-24 | 4 | 9 | 3 | 2 | 2 | 1 | 1 | |||
| 10 | Ford | Domantas Šeimys | 2022-12-01 | 1 | 10 | 3 | 2 | 2 | 1 | 1 | 1 | ||
| 11 | Ford | Rusnė Rimaitė | 2022-12-01 | 1 | 10 | 3 | 2 | 2 | 1 | 1 | 1 | ||
| 12 | Ford | Martynas Jurgis Bireta | 2022-12-01 | 1 | 10 | 3 | 2 | 2 | 1 | 1 | 1 | ||
| 13 | LVMH | Aivaras Kuzmickas | 2022-11-24 | 5 | 10 | 3 | 2 | 2 | 1 | 1 | 1 | ||
| 14 | LVMH | Tadas Bugailiskis | 2022-11-24 | 5 | 10 | 3 | 2 | 2 | 1 | 1 | 1 | ||
| 15 | LVMH | Jan-Kaspar Steves | 2022-11-24 | 5 | 10 | 3 | 2 | 2 | 1 | 1 | 1 | ||
| 16 | Aegon NV | Ieva Jankauskytė | 2022-12-01 | 2 | 10 | 3 | 2 | 2 | 1 | 1 | 1 | ||
| 17 | Netflix | Liutauras Velička | 2022-11-24 | 6 | 10 | 3 | 2 | 2 | 1 | 1 | 1 | ||
| 18 | Netflix | Glorija Kaminskaitė | 2022-11-24 | 6 | 9 | 3 | 2 | 2 | 1 | 1 | |||
| 19 | Netflix | Justina Sahmel | 2022-11-24 | 6 | 10 | 3 | 2 | 2 | 1 | 1 | 1 | ||
| 20 | Christian Dior | Kestutis Tautvydas Telycenas | 2022-12-01 | 3 | 10 | 3 | 2 | 2 | 1 | 1 | 1 | ||
| 21 | Christian Dior | Ieva Poniskaityte | 2022-12-01 | 3 | 10 | 3 | 2 | 2 | 1 | 1 | 1 | ||
| 22 | Christian Dior | Emilija Vanceviciute | 2022-12-01 | 3 | 10 | 3 | 2 | 2 | 1 | 1 | 1 | ||
| 23 | Spotify | Amrah Abbaszade | 2022-12-01 | 4 | 8 | 3 | 2 | 1 | 1 | 1 | |||
| 24 | Spotify | Namig Javadli | 2022-12-01 | 4 | 9 | 3 | 2 | 1 | 1 | 1 | 1 | ||
| 25 | Spotify | Dildar Tagiyev | 2022-12-01 | 4 | 9 | 3 | 2 | 1 | 1 | 1 | 1 | ||
| Spotify | Christian Barbarisi | 2022-12-01 | 4 | 9 | 3 | 2 | 1 | 1 | 1 | 1 | |||
| 26 | Walmart (WMT) | Greta Šulcaitė | 2022-12-01 | 6 | 9 | 3 | 2 | 2 | 1 | 1 | |||
| 27 | Walmart (WMT) | Alexander Carl Chistensen Quintana | 2022-12-01 | 6 | 10 | 3 | 2 | 2 | 1 | 1 | 1 | ||
| Walmart (WMT) | Elif Ilayda Ince | 2022-12-01 | 6 | 10 | 3 | 2 | 2 | 1 | 1 | 1 | |||
| 28 | American Express | Lukaš Kolpak | 2022-12-01 | 7 | 10 | 3 | 2 | 2 | 1 | 1 | 1 | ||
| 29 | American Express | Justas Sadauskas | 2022-12-01 | 7 | 10 | 3 | 2 | 2 | 1 | 1 | 1 | ||
| 30 | Ose Immunotherapeutics | Aistė Stračinkytė | 2022-12-01 | 5 | 10 | 3 | 2 | 2 | 1 | 1 | 1 | ||
| 31 | Ose Immunotherapeutics | Miglė Balčiūnaitė | 2022-12-01 | 5 | 9 | 3 | 2 | 2 | 1 | 1 | |||
| 32 | Ose Immunotherapeutics | Todd Tautvydas | 2022-12-01 | 5 | 10 | 3 | 2 | 2 | 1 | 1 | 1 | ||
| 33 | FC Barcelona | Ugnius Vainevičius | 2022-12-08 | 3 | 0 | ||||||||
| 34 | FC Barcelona | Ričardas Ratkevičius | 2022-12-08 | 3 | 0 | ||||||||
| 35 | Mondelez International | Ignas Galvičius | 2022-12-08 | 2 | 0 | ||||||||
| 36 | Mondelez International | Liudas Vaitiekūnas | 2022-12-08 | 2 | 0 | ||||||||
| 37 | Johnson & Johnson | Deimantė Bakaitytė | 2022-12-08 | 4 | 1 | 1 | |||||||
| 38 | Johnson & Johnson | Ignas Malinauskas | 2022-12-08 | 4 | 0 | ||||||||
| 39 | 0 | ||||||||||||
| 40 | 0 | ||||||||||||